AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Chronic Liver Disease

Vitamin D2 vs Vitamin D2 Plus Calcitriol in Cholestatic Children With Vitamin D Deficiency NCT07670611Phase 41 site๐Ÿ“ Bangkok Chulalongkorn University ยท Tests: Vitamin D2, Calcitriol Direct Portal Pressure Measurement Via Endoscopic Ultrasound in Advanced Chronic Liver Disease (EVADIPP) NCT06266260n/a1 site๐Ÿ“ Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: EUS PPG measurement Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) NCT05870969n/a1 site๐Ÿ“ Shanghai Ruijin Hospital ยท Tests: Liver cancer surveillance every 3 months, Liver cancer surveillance every 6 months, Liver cancer surveillance annually Belimumab in Autoimmune Hepatitis NCT06381453Phase 26 sites๐Ÿ“ Calgary๐Ÿ“ Vancouver๐Ÿ“ Hamilton University Health Network, Toronto ยท Tests: Belimumab Auto-Injector [Benlysta] Comorbidities Resolution After MGB Surgery and Change in Body Composition NCT06015620n/a1 site๐Ÿ“ Bhubaneswar All India Institute of Medical Sciences, Bhubaneswar ยท Tests: Mini gastric bypass surgery Impact of Liver Transplantation on Sexual Life and Function NCT07268196n/a1 site๐Ÿ“ New Delhi Institute of Liver and Biliary Sciences, India ยท Tests: No Treatment SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus NCT06364930Phase 41 site๐Ÿ“ Hong Kong Chinese University of Hong Kong ยท Tests: Dapagliflozin 10mg Tab, Placebo 10mg Tab Pegylated Interferon ฮฑ in Previously Interferon-treated CHB๏ผˆLeading Study๏ผ‰ NCT06323681NA1 site๐Ÿ“ Shanghai Qing XIe ยท Tests: Peginterferon ฮฑ-2b based treatment group, NAs monotherapy group Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK) NCT03792919Phase 41 site๐Ÿ“ Hong Kong Humanity & Health Medical Group Limited ยท Tests: Stop current treatment (anti-HBV neucleos(t)ides), Keep current treatment (anti-HBV neucleos(t)ides) Prediction of Significant Liver Fibrosis NCT06509230n/a1 site๐Ÿ“ Hangzhou Huang Haijun ยท Tests: Non-Invasive Model for Fibrosis Regression in HBV Patients NCT06874127n/a1 site๐Ÿ“ Beijing Beijing Friendship Hospital ยท Tests: Nucleos(t)ide Analogs (NA) Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF NCT03920618NA1 site๐Ÿ“ Guangzhou Third Affiliated Hospital, Sun Yat-Sen University ยท Tests: Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study). NCT07487623NA2 sites๐Ÿ“ Guadalajara๐Ÿ“ Guadalajara University of Guadalajara ยท Tests: resveratrol, quercetin, taurine, whey protein, and inulin, whey protein Carotid Artery Corrected Flow Time and Respiratory Variation of Blood Flow Peak Velocity for Prediction of Hypotension After Induction of General Anaesthesia in Adult Patients With Chronic Liver Disease NCT07370103n/a1 site๐Ÿ“ Cairo Ain Shams University TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load. NCT05195450NA1 site๐Ÿ“ New Delhi Institute of Liver and Biliary Sciences, India ยท Tests: Tenofovir alafenamide fumarate Evaluation of Patients With Liver Disease NCT00001971n/a1 site๐Ÿ“ Bethesda National Institute of Diabetes and Digestive and Kidney Disโ€ฆ Copper Supplementation in Cirrhosis NCT07471542NA1 site๐Ÿ“ Seattle University of Washington ยท Tests: Copper Gluconate EUS-guided Portal Pressure Gradient (PPG) Measurement: a Potential Alternative to the Traditional HVPG NCT06863012NA1 site๐Ÿ“ Barcelona Fundacio Privada Mon Clinic Barcelona ยท Tests: Endoscopic Ultrasound-Guided Portal Pressure Gradient (EUS-PPG) Measurement, Hepatic Venous Pressure Gradient (HVPG) Meโ€ฆ Swiss Autoimmune Hepatitis Cohort Study NCT03146884n/a20 sites๐Ÿ“ Lugano๐Ÿ“ Basel๐Ÿ“ Basel Fondazione Epatocentro Ticino Assessing Signatures for Fibrosis Detection in Chronic Liver Disease: A Step Beyond Conventional Biomarkers NCT07359742NA1 site๐Ÿ“ Brussels Universitair Ziekenhuis Brussel ยท Tests: Blood draw for biomarkers Referral of Patients to Hepatology With Hepatoscope NCT06387745NA1 site๐Ÿ“ Edegem University Hospital, Antwerp ยท Tests: Hepatoscope Study on the Quantitative Assessment of the Risk of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Using Multi-parameter Magnetic Resonance Imaging NCT06060769n/a1 site๐Ÿ“ Zhuhai Fifth Affiliated Hospital, Sun Yat-Sen University Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B NCT04896255n/a1 site๐Ÿ“ Shanghai Huashan Hospital ยท Tests: peginterferon alpha based regimen, nucleos(t)ide Combined Use of Bacteroides Fragilis and BCAAs on HBsAg Clearance NCT07257562n/a1 site๐Ÿ“ Fuzhou First Affiliated Hospital of Fujian Medical University ยท Tests: PegIFNฮฑ2b+Nucleoside analog, PegIFNฮฑ2b+Nucleoside analog+Bacteroides fragilis+Branched-Chain Amino Acids A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition NCT05519475Phase 271 sites๐Ÿ“ Flagstaff๐Ÿ“ Peoria๐Ÿ“ Tucson Regeneron Pharmaceuticals ยท Tests: ALN-HSD, Placebo Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B NCT03933384Phase 41 site๐Ÿ“ Taichung Taichung Veterans General Hospital ยท Tests: Tenofovir alafenamide, Entecavir TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B NCT04843852Phase 11 site๐Ÿ“ Baltimore University of Maryland, Baltimore ยท Tests: Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B] Multi-parametric Magnetic Resonance Imaging for the Precise Diagnosis and Quantitative Study of Liver Steatosis, Inflammation, and Fibrosis in Chronic Liver Disease. NCT06463366n/a1 site๐Ÿ“ Shenyang Shengjing Hospital ยท Tests: 3D-MRE,MRI-PDFF Assessment of Changes in Bone Mineral Metabolism After Liver Transplantation by Bone Mineral Densitometry NCT07480057n/a1 site๐Ÿ“ New Delhi Institute of Liver and Biliary Sciences, India ยท Tests: no intervention Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D Infection NCT07610772Phase 12 sites๐Ÿ“ Aarhus๐Ÿ“ Berlin Aarhus University Hospital ยท Tests: HepB mAb19
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy